...
search icon
scni-img

Scinai Immunotherapeutics Ltd, Common Stock

SCNI

NAQ

$2.52

+$0.15

(6.33%)

1D
Industry: Semiconductors & Semiconductor Equipment Sector: Information Technology

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.26M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
76.74K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.09
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.9 L
$5.89 H
$2.52

About Scinai Immunotherapeutics Ltd, Common Stock

Scinai Immunotherapeutics Ltd., a biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel. It develops nanosized VHH antibodies (nanoAbs) targeting diseases with unmet medical needs; and PC111, a monoclonal antibody for treating pemphigus, steven johnson's syndrome, and toxic epidermal necrolysis. The company also provides contract development and manufacturing organization services to biotech companies. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Gottingen for the development and commercialization of COVID-19 nanosized antibody. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel. more

Industry: Semiconductors & Semiconductor EquipmentSector: Information Technology

Returns

Time FrameSCNISectorS&P500
1-Week Return11.5%2.33%1.86%
1-Month Return-12.89%6.48%2.96%
3-Month Return-25.09%13.23%5.43%
6-Month Return-26.74%2.72%1.2%
1-Year Return-18.45%9.16%11.33%
3-Year Return-97.94%86.53%55.98%
5-Year Return-99.9%138.69%97.15%
10-Year Return-99.49%480.1%190.74%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue----658.00K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue708.92K747.65K559.80K512.67K1.24M[{"date":"2020-12-31","value":57.26,"profit":true},{"date":"2021-12-31","value":60.39,"profit":true},{"date":"2022-12-31","value":45.22,"profit":true},{"date":"2023-12-31","value":41.41,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit---(512.67K)(580.00K)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Gross Margin----(88.15%)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-88.15,"profit":false}]
Operating Expenses(2.28M)10.05M11.06M9.18M8.06M[{"date":"2020-12-31","value":-20.63,"profit":false},{"date":"2021-12-31","value":90.83,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":82.97,"profit":true},{"date":"2024-12-31","value":72.85,"profit":true}]
Operating Income2.28M(10.87M)(11.06M)(9.71M)(8.64M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-476.51,"profit":false},{"date":"2022-12-31","value":-484.71,"profit":false},{"date":"2023-12-31","value":-425.33,"profit":false},{"date":"2024-12-31","value":-378.53,"profit":false}]
Total Non-Operating Income/Expense(7.33M)(8.19M)10.53M3.33M12.10M[{"date":"2020-12-31","value":-60.59,"profit":false},{"date":"2021-12-31","value":-67.71,"profit":false},{"date":"2022-12-31","value":87.01,"profit":true},{"date":"2023-12-31","value":27.52,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(1.39M)(8.21M)(5.80M)(6.50M)4.80M[{"date":"2020-12-31","value":-28.9,"profit":false},{"date":"2021-12-31","value":-171.1,"profit":false},{"date":"2022-12-31","value":-120.85,"profit":false},{"date":"2023-12-31","value":-135.53,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes(26.35M)3.48M333.51K0.28-[{"date":"2020-12-31","value":-756.85,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":9.58,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes24.96M(11.69M)(6.13M)(6.50M)-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-46.82,"profit":false},{"date":"2022-12-31","value":-24.56,"profit":false},{"date":"2023-12-31","value":-26.04,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(1.39M)(39.98M)(5.80M)(6.50M)4.80M[{"date":"2020-12-31","value":-28.89,"profit":false},{"date":"2021-12-31","value":-833.57,"profit":false},{"date":"2022-12-31","value":-120.85,"profit":false},{"date":"2023-12-31","value":-135.53,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(1.39M)(8.21M)(5.80M)(6.50M)4.80M[{"date":"2020-12-31","value":-28.9,"profit":false},{"date":"2021-12-31","value":-171.1,"profit":false},{"date":"2022-12-31","value":-120.85,"profit":false},{"date":"2023-12-31","value":-135.53,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
EPS (Diluted)(0.31)(1.15)-(25.41)4.98[{"date":"2020-12-31","value":-6.24,"profit":false},{"date":"2021-12-31","value":-23.03,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-510.69,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Ratios

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SCNI
ROA (LTM) -34.92%
ROE (LTM) 177.37%

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SCNI
Trailing PE NM
Forward PE NM
P/S (TTM) 3.60
P/B 0.51
Price/FCF NM
EV/R 12.13
EV/Ebitda 1.01

FAQs

What is Scinai Immunotherapeutics Ltd share price today?

Scinai Immunotherapeutics Ltd (SCNI) share price today is $2.52

Can Indians buy Scinai Immunotherapeutics Ltd shares?

Yes, Indians can buy shares of Scinai Immunotherapeutics Ltd (SCNI) on Vested. To buy Scinai Immunotherapeutics Ltd from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SCNI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Scinai Immunotherapeutics Ltd be purchased?

Yes, you can purchase fractional shares of Scinai Immunotherapeutics Ltd (SCNI) via the Vested app. You can start investing in Scinai Immunotherapeutics Ltd (SCNI) with a minimum investment of $1.

How to invest in Scinai Immunotherapeutics Ltd shares from India?

You can invest in shares of Scinai Immunotherapeutics Ltd (SCNI) via Vested in three simple steps:

  • Click on Sign Up or Invest in SCNI stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Scinai Immunotherapeutics Ltd shares
What is Scinai Immunotherapeutics Ltd 52-week high and low stock price?

The 52-week high price of Scinai Immunotherapeutics Ltd (SCNI) is $5.89. The 52-week low price of Scinai Immunotherapeutics Ltd (SCNI) is $1.9.

What is Scinai Immunotherapeutics Ltd price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Scinai Immunotherapeutics Ltd (SCNI) is 0.51

What is the Market Cap of Scinai Immunotherapeutics Ltd?

The market capitalization of Scinai Immunotherapeutics Ltd (SCNI) is $2.26M

What is Scinai Immunotherapeutics Ltd’s stock symbol?

The stock symbol (or ticker) of Scinai Immunotherapeutics Ltd is SCNI

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top